| Joseph H Berman, MD | |
|
1743 West Redstone Center Ste 115, Park City, UT 84098-7600 | |
| (435) 658-9200 | |
| Not Available |
| Full Name | Joseph H Berman |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 1743 West Redstone Center Ste 115, Park City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780772624 | NPI | - | NPPES |
| 119172100 | Medicaid | WY | |
| D1043 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 185433-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph H Berman, MD Po Box 510708, Salt Lake City, UT 84151-0708 Ph: (801) 587-6600 | Joseph H Berman, MD 1743 West Redstone Center Ste 115, Park City, UT 84098-7600 Ph: (435) 658-9200 |
News Archive
Many different tissues and organs form from pluripotent stem cells during embryonic development. To date it had been known that these processes are controlled by transcription factors for specific tissues. Scientists from the Max Planck Institute for Molecular Genetics in Berlin, in collaboration with colleagues at MIT and the Broad Institute in Boston, have now been able to demonstrate that RNA molecules, which do not act as templates for protein synthesis, participate in these processes as well.
The H1N1 (swine flu) virus has now infected more than 52,000 people, leaving 231 dead, the WHO said Monday, AFP/Washington Post reports.
Researchers from Australia's Curtin University have developed a simple pill that could be used to treat methamphetamine addicts. It would soon be tried in a clinical trial to prove its efficacy and utility said the researchers.
Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.
HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a land mark paper in The Lancet.
› Verified 7 days ago
Dr. Joseph Ferriter, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1665 Bonanza Dr, Park City, UT 84060 Phone: 435-649-7640 Fax: 435-649-1365 | |
John Joseph Hanrahan, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 510 Maple Dr, Park City, UT 84098 Phone: 435-714-0715 | |
Dr. Kenneth Alan Wolkoff, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3065 Fawn Dr, Park City, UT 84098 Phone: 435-655-8212 | |
Brian J Rush, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2720 Homestead Rd, Ste 100, Park City, UT 84098 Phone: 435-940-9400 | |
Bradley Cris Cowley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Round Valley Dr, Park City, UT 84060 Phone: 435-658-7000 | |
Dr. Spenser Reed, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1790 Sun Peak Dr Ste A101, Park City, UT 84098 Phone: 435-645-0800 | |
Stefani Jane Day, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1665 Bonanza Dr, Park City, UT 84060 Phone: 435-649-7640 Fax: 435-645-7768 |